
Pictet Alternative Advisors
Route des Acacias 60, Geneva, Geneve, 1211 Geneva 73, Switzerland
Overview
Private banking and asset management services.
Founded
1805
Deals · 12mo
2
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Kinaset Therapeutics | Jan 2026Participated | $103 MSeries B | |
Syremis Therapeutics | Dec 2025Participated | $165 MSeries A | |
Azafaros | May 2025Participated | $155 MSeries B | |
Mainspring Energy | Apr 2025Participated | $258 MSeries F | |
Fairmat | Apr 2025Participated | $61 MSeries B | |
Unique | Feb 2025Participated | $30 MSeries A | |
Atalanta Therapeutics | Jan 2025Participated | $97 MSeries B | |
Antag Therapeutics | Dec 2024Participated | $93 MSeries A | |
Caresyntax | Aug 2024Participated | $180 MDebt | |
RefleXion Medical | Nov 2023Participated | $105 MOther Equity | |
Honasa Consumer | Oct 2023Participated | $92 MOther Equity | |
Harbinger Health | Sep 2023Led | $140 MSeries B | |
Kinaset Therapeutics | Jan 2026Participated | $103 MSeries B | |
Syremis Therapeutics | Dec 2025Participated | $165 MSeries A | |
Azafaros | May 2025Participated | $155 MSeries B | |
Mainspring Energy | Apr 2025Participated | $258 MSeries F | |
Fairmat | Apr 2025Participated | $61 MSeries B | |
Unique | Feb 2025Participated | $30 MSeries A | |
Atalanta Therapeutics | Jan 2025Participated | $97 MSeries B | |
Antag Therapeutics | Dec 2024Participated | $93 MSeries A | |
Caresyntax | Aug 2024Participated | $180 MDebt | |
RefleXion Medical | Nov 2023Participated | $105 MOther Equity | |
Honasa Consumer | Oct 2023Participated | $92 MOther Equity | |
Harbinger Health | Sep 2023Led | $140 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 4 |
| Series B | 1 | 6 |
| Series C+ | 0 | 7 |
| Other Equity | 1 | 3 |
| Debt | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Feb '18 | 1 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 1 |
| Nov '20 | 0 |
| Dec '20 | 1 |
| Jan '21 | 0 |
| Feb '21 | 1 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 1 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 1 |
| Oct '22 | 1 |
| Nov '22 | 1 |
| Dec '22 | 1 |
| Jan '23 | 0 |
| Feb '23 | 1 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 2 |
| Oct '23 | 1 |
| Nov '23 | 1 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 1 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 1 |
| Jan '25 | 1 |
| Feb '25 | 1 |
| Mar '25 | 0 |
| Apr '25 | 2 |
| May '25 | 1 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 1 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 17 |
| AI & Machine Learning | 5 |
| Clean Energy & Sustainability | 4 |
| Consumer & Lifestyle | 4 |
| Data, Analytics & IT | 3 |
| Fintech | 3 |
| Manufacturing | 3 |
| Enterprise Software | 2 |
| Space & Frontier Tech | 2 |
| Food & Agriculture | 2 |
| Cybersecurity & Privacy | 1 |
| Transportation & Logistics | 1 |
| Hardware & Robotics | 1 |
| Marketing & Advertising | 1 |
| Media & Entertainment | 1 |
| Professional Services | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 1 |
| $25M-$50M | 2 |
| $50M-$100M | 6 |
| $100M-$250M | 11 |
| $250M-$500M | 2 |
| $500M-$1B | 1 |
| $1B+ | 0 |
Deals By Geography
Top 5 of 5 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 13 |
| Europe | 7 |
| Israel | 1 |
| Saudi Arabia | 1 |
| India | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Flagship Pioneering | 5 |
| Abu Dhabi Investment Authority | 3 |
| Fidelity Management & Research Company | 3 |
| Temasek | 3 |
| Alexandria Venture Investments | 2 |
| Bain Capital Life Sciences | 2 |
| Credit Suisse | 2 |
| EQT Life Sciences (LSP) | 2 |
| F-Prime Capital | 2 |
| Gimv | 2 |
| Jeito Capital | 2 |
| Johnson & Johnson Innovation | 2 |
| Schroders Capital | 2 |
| Singular | 2 |
| SR One | 2 |
| T. Rowe Price Associates | 2 |
| Vivo Capital | 2 |
| 5AM Ventures | 1 |
| abrdn | 1 |
| ACE & Company | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 2 | 9% |
| Participating | 21 | 91% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 2 | 100% |
Team
Senior Frontend Developer
Project Manager - Strategy & Finance⎜Pictet Trading & Sales
Head of Communications & Branding
Independent Director, audit Committee chair, risk committee member, bank pictet and Cia
Group Managing Director & Head of Communications